중앙 검사실 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Central Lab Market size is expected to reach USD 7.78 Billion in 2034 from USD 4.27 Billion (2025) growing at a CAGR of 6.9% during 2026-2034.

The Global Central Lab Market is witnessing strong growth driven by the increasing number of clinical trials and research activities worldwide. Pharmaceutical and biotechnology companies rely on central labs for standardized testing and data management during multi-center trials. The growing focus on drug development and personalized medicine is significantly boosting demand for central laboratory services.

Outsourcing laboratory services to central labs helps reduce operational costs and ensure consistent quality standards. Technological advancements in diagnostic testing and data integration systems are enhancing service efficiency. Additionally, the rise in chronic diseases and demand for innovative therapies are fueling clinical trial activities, further strengthening the market outlook.

In the coming years, the central lab market is expected to benefit from increased investments in research and development. Expanding clinical trials in emerging markets will create new opportunities for service providers. As regulatory requirements become more stringent and data accuracy becomes critical, central labs will play an increasingly vital role in supporting global drug development initiatives.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Services

• Genetic Services
• Biomarker Services
• Microbiology Services
• Anatomic Pathology / Histology
• Specimen Management & Storage
• Special Chemistry Services
• Others

By End-Use

• Pharmaceutical Companies
• Biotechnology Companies
• Academic And Research Institutes

COMPANIES PROFILED

• ACM Global Laboratories, Labconnect, Cerba Research, Eurofins Scientific, Medicover Integrated Clinical Services MICS Synevo Central Labs, Versiti Cenetron, AP Mller Holding AS Unilabs, Ampersand Capital Partners Pacific Biomarkers, Lambda Therapeutics Research Ltd, Cirion Biopharma Research Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CENTRAL LAB MARKET: BY SERVICES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Services
• 4.2. Genetic Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Biomarker Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Microbiology Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Anatomic Pathology / Histology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Specimen Management & Storage Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Special Chemistry Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CENTRAL LAB MARKET: BY END-USE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End-use
• 5.2. Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Academic And Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CENTRAL LAB MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Services
  • 6.2.2 By End-use
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Services
  • 6.3.2 By End-use
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Services
  • 6.4.2 By End-use
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Services
  • 6.5.2 By End-use
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Services
  • 6.6.2 By End-use
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL CENTRAL LAB INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 ACM Global Laboratories
  • 8.2.2 Labconnect
  • 8.2.3 Cerba Research
  • 8.2.4 Eurofins Scientific
  • 8.2.5 Medicover Integrated Clinical Services (MICS) (Synevo Central Labs)
  • 8.2.6 Versiti (Cenetron)
  • 8.2.7 A.P. MAfA,Ller Holding A/S (Unilabs)
  • 8.2.8 Ampersand Capital Partners (Pacific Biomarkers)
  • 8.2.9 Lambda Therapeutics Research Ltd
  • 8.2.10 Cirion Biopharma Research Inc